نتائج البحث - David Cirelli

  • يعرض 1 - 6 نتائج من 6
تنقيح النتائج
  1. 1
    The Race to Develop the Pfizer-BioNTech COVID-19 Vaccine: From the Pharmaceutical Scientists’ Perspective

    The Race to Develop the Pfizer-BioNTech COVID-19 Vaccine: From the Pharmaceutical Scientists’ Perspective حسب Lavinia M. Lewis, Advait Badkar, David Cirelli, Rodney G. Combs, Thomas F. Lerch

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Oligonucleotide mapping via mass spectrometry to enable comprehensive primary structure characterization of an mRNA vaccine against SARS-CoV-2

    Oligonucleotide mapping via mass spectrometry to enable comprehensive primary structure characterization of an mRNA vaccine against SARS-CoV-2 حسب Brian Gau, Andrew Dawdy, Hanliu Leah Wang, Bradley Bare, Carlos H. Castaneda, Olga Friese, Matthew S. Thompson, Thomas F. Lerch, David Cirelli, Jason C. Rouse

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Characterization of BNT162b2 mRNA to Evaluate Risk of Off-Target Antigen Translation

    Characterization of BNT162b2 mRNA to Evaluate Risk of Off-Target Antigen Translation حسب Himakshi Patel, Kun Zhang, Rachael Utegg, Elaine Stephens, Shauna Salem, Heidi C. E. Welch, Svenja Grobe, Julia Schlereth, Andreas N. Kuhn, Jeff Ryczek, David Cirelli, Thomas F. Lerch

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity

    Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity حسب Dina Scarpi, David Cirelli, Carmela Matrone, Giuseppe Castronovo, Paolo Rosini, Ernesto G. Occhiato, Federico Romano, Laura Bartali, Ann Maria Clemente, Giovanni Bottegoni, Andrea Cavalli, Giovanna De Chiara, С. Бонини, Pietro Calissano, Anna Teresa Palamara, Enrico Garaci, Maria Gabriella Torcia, Antonio Guarna, F Cozzolino

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Errata/Corrigenda
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    A novel in-vitro expression assay by LC/MS/MS enables multi-antigen mRNA vaccine characterization

    A novel in-vitro expression assay by LC/MS/MS enables multi-antigen mRNA vaccine characterization حسب Hanliu Leah Wang, Kimia Kajbaf, Brian Gau, Andrew Dawdy, Rachel Edwards, Bradley Bare, Gianna Raymundo, Jose Iturrizaga, Chase Ernsky, Michael S. Walker, Emilia B. Byrne, James Boslett, Adam G. Campbell, Roman Matthessen, Ben Goffin, David Cirelli, Jason C. Rouse, Robbe Van Pottelberge, Olga Friese

    منشور في 2025
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Establishing <i>in vitro in vivo</i> correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics

    Establishing <i>in vitro in vivo</i> correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics حسب Lindsay B. Avery, Jason Wade, Mengmeng Wang, Amy Tam, Amy King, Nicole Piche‐Nicholas, Mania Kavosi, Steve Penn, David Cirelli, Jeffrey C. Kurz, Minlei Zhang, Orla Cunningham, Rhys D.O. Jones, Brian J. Fennell, Barry J. McDonnell, Paul Sakorafas, James R. Apgar, William J.J. Finlay, Laura Lin, Laird Bloom, Denise M. O’Hara

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: